“a nonsignificant trend”

No significant relationship between pattern similarity and behavior, despite the same response type, was observed for positive stimuli (left CA1: r = −0.015, P = 0.93; right CA1: r = −0.16, P = 0.35; vmPFC: r = 0.09, P = 0.59; dmPFC: r = 0.19, P = 0.27) (Supplemental Figure S3), and only a nonsignificant trend for neutral stimuli was observed (left CA1: r = 0.40, P = 0.018; right CA1: r = 0.30, P = 0.08; vmPFC: r = 0.29, P = 0.09; dmPFC: r = 0.13, P = 0.46; Supplemental Figure S4).

Group differences in regional volumes Group comparisons ( t -tests) showed right putamen volume loss (HC: M = 0.35, SD = 0.05; PD-woMCI: M = 0.33, SD = 0.04; p = 0.005) and a nonsignificant trend for left putamen volume loss (HC: M = 0.36, SD = 0.06; PD-woMCI: M = 0.34, SD = 0.04; p = 0.02) in the PD-woMCI group.

Dividing the cases by tumor subtype, the FOXP3+ survival improvement was observed in UUS, and as a nonsignificant trend in ESS ( p = 0.0269 and p = 0.0954, respectively), but not in LMS (Supplementary Fig. 3 ).

There was a nonsignificant trend toward higher KYN/TRP ratios in plasma in the HIV+ group ( P = 0.027; Bonferroni corrected α = 0.0027).

In contrast, the placebo responders showed a nonsignificant trend for a decrease in CPM response, which is a less effective response (more pro-nociceptive pain modulation), after 3 weeks of treatment ( P =0.028) ( Table 2 ).

With CCR2 V64I SNP we noticed a nonsignificant trend of increased frequency of 64I allele in patients with intermediate uveitis as compared to controls (p=0.03, pc=0.09).

There was a nonsignificant trend for improvement in the fastest 10% RT (Intercept = 211.72, Week 6 of App Use = −7.45; CI = −14.46–−0.44, p = 0.03) and number of lapses (Intercept = 4.98, Week 6 of App Use = −1.06; CI = −2.27–0.16, p = 0.08).

Only TG showed nominally significant difference between the three stenosis groups ( P = 0.03), followed by a nonsignificant trend of difference observed for TC ( P = 0.43) ( Table 1 ).

A one-way repeated measures ANOVA revealed a significant main effect of condition, F (4, 71) = 42.34, p < 0.001, with significantly better performance for face and text than all other categories, all t > 6.4, p < 0.001, and no further significant differences, but a nonsignificant trend for eyes compared with noses, t (71) = 2.20, p = 0.031, all other t < 1.44, p > 0.15 ( Supplementary Figure S3 a).

We then applied this tract-specific mask from Dataset 1 to the other two data sets, and also found a significant relationship between the FA values and STAI-T scores, which was observed bilaterally in Dataset 2 (right, r = −0.2, p = 0.031; left, r = −0.212, p = 0.022; both q s < 0.05), and a nonsignificant trend in Dataset 3 (right, r = −0.301, p = 0.032; left, r = −0.23, p = 0.105).

Unmarked MP cagemates ( p = 0.001), and possibly EP+A mice ( p = 0.034; a nonsignificant trend), grimaced the most.

Compared with the vehicle group, esaxerenone monotherapy showed a nonsignificant trend toward a decrease in MCP-1 excretion at 4 ( P = 0.036, n = 11) and 8 weeks ( P = 0.078, n = 11); however, there were no specific effects with olmesartan alone.

In both fibromyalgia and nonfibromyalgia groups, women showed a nonsignificant trend towards presenting lower values in reduced activity from the MFI ( P ≤ 0.038).

Grade 2 or higher RP showed significance for DMFS and a nonsignificant trend for OS (HR 2.28, p = 0.04 and HR 2.12, p = 0.13), respectively, whereas a higher percentage of lung volume receiving 20 Gy or higher was significant for PFS (HR 2.25, p = 0.01).

2 B) and at a nonsignificant trend also the SAN (p = .04, r = 0.62, η 2 = 0.06) ( Fig. 2 C) predicted higher current warmth score, but as predicted the DMN control network was not significant (Supplementary Fig. 2A).

Poor sleep efficiency in AD dementia showed a nonsignificant trend with informant report of daytime sleepiness based on the Epworth Sleepiness Scale ( r = −0.43, P <0.04).

At 18 h after administration, the %ID for the stomach contents in the 211 At-anti-HER2 mAb (ATE) group was significantly higher than in the 211 At-anti-HER2 mAb (MSB) group, accompanied by a nonsignificant trend toward higher %ID/g (%ID, P = 0.042; %ID/g, P = 0.442) ( Figure A,B). 3.5.

Beyond fatigue measures, viewing distance showed a nonsignificant trend toward reduction with longer duration ( p = 0.046).

Additionally, there was a nonsignificant trend towards multiple repeat mutations (p = 0.5127), as well as, a nominally significant trend towards deletion mutations (p = 0.0495) (Table 6 ).

After 60 minutes of efflux time, a nonsignificant trend ( P > 0.05) of a higher efflux ratio for the double transfectant model HEK OATP2B1WT-MRP1var was observed compared with cell lines expressing WT MRP1 (HEK OATP2B1WT-MRP1WT and HEK OATP2B1var-MRP1WT ).

The IL1β rs1143623 T allele showed a nonsignificant trend towards association with lower odds for developing OH (OR = 0.57; 95%CI = 0.32–1.00, p = 0.050), while heterozygotes had nominally significant lower odds for developing OH (OR = 0.51; 95%CI = 0.28–0.93, p = 0.028).

Patients administered platinum-based regimens showed significantly longer progression-free survival (hazard ratio 0.55, 95% confidence interval 0.37-0.82, P = 0.004) and a nonsignificant trend toward improved overall survival (hazard ratio 0.76, 95% confidence interval 0.57-1.00, P = 0.05).

Serum TMAO, carnitine, and choline levels were significantly higher in patients with NMIBC than in controls ( p ≤ 0.0001), whereas betaine showed a nonsignificant trend toward higher levels ( p ≥ 0.05).

The 24 mg dose and 3 mg dose demonstrated a nonsignificant trend toward BMI reduction ( p = 0.05).

RESULTS Germination rates after 7 days were slightly higher for the autumn experiments (96.1%) than for the winter/spring experiments (94.8%) ( P > 0.05), with a nonsignificant trend of more seedlings having germinated in the verum group in the autumn experiments ( P > 0.05) (see Table 2 ).